Emtricitabintriphosphat og tenofovirdiphosphat hæmmer kompetitivt HIV- 1 revers transkriptase, hvilket resulterer i DNA - kædeblokering.
Emtricitabine triphosphate and tenofovir diphosphate competitively inhibit HIV-1 reverse transcriptase, resulting in DNA chain termination.